Navigation Links
Dallas' Charla Aldous Earns 'Trial Lawyer of the Year' Award
Date:9/25/2008

Successful attorney honored by Texas chapters of American Board of Trial

Advocates

DALLAS, Sept. 25 /PRNewswire/ -- Charla G. Aldous, founder of Dallas' Aldous Law Firm, has earned the 2008 "Trial Lawyer of the Year" award from the Texas chapters of the American Board of Trial Advocates. She will receive the award at the TEX-ABOTA annual meeting on Oct. 25, 2008, at Lost Pines Resort in Bastrop, Texas.

The TEX-ABOTA Board of Directors selected Aldous as "Trial Lawyer of the Year" after reviewing numerous nominations submitted by chapters across the state.

"Charla is the epitome of those whom we seek to honor with the 'Trial Lawyer of the Year' award," says Dicky Grigg, President of TEX-ABOTA. "Her courtroom record is enviable, and she has unselfishly shared her leadership skills through public service to the legal profession and her community."

A 23-year veteran of more than 100 trials, Aldous has secured hundreds of millions of dollars in verdicts and settlements on behalf of her clients. In 2007, Texas Lawyer newspaper named her one of the top five personal injury attorneys in Texas, and she has been listed as one of the "Ten Winning Lawyers in America" by The National Law Journal.

She has appeared on the cover of Texas Super Lawyers magazine, where she has been featured among the top 100 lawyers in the state, and D Magazine routinely includes her in its listing of the Best Lawyers in Dallas. Aldous' work twice has been recognized in Lawyers Weekly among the "Top 10 Verdicts in the Nation," and she also is a member of the Inner Circle of Advocates, an invitation-only group of 100 of the country's leading plaintiff's lawyers.

"My primary focus is to make sure my clients receive justice, and that also serves as one of ABOTA's key missions," says Aldous. "Texas is home to many great trial lawyers, and it is a tremendous honor to receive this award from an outstanding organization."


'/>"/>
SOURCE Aldous Law Firm
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dallas Cardiologists Explore Next Frontier in Vascular-Disease Treatments
2. Gustav: World Vision Teams Assist Evacuees in Jackson and Dallas, Prepare Response
3. Elizabeth Edwards to be Opening Speaker at National Hospice Conference in Dallas
4. Colombia Appoints Dallas Chiropractor to Olympic Team
5. Lucas Group to Host Military Hiring Conferences in Washington, DC; Irvine, CA and Dallas, TX
6. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
7. Solis Womens Health Brings Molecular Breast Imaging to Dallas-Fort Worth Metroplex
8. Chair of Radiology at Presbyterian Hospital of Dallas Named President of American College of Physician Executives
9. Echocardiography Lab at Presbyterian Hospital of Dallas Achieves Prestigious Reaccreditation
10. KGS Bikes Offers Fittings to Dallas Discriminating Cyclists
11. CRH Medical Corporation opens Center in Dallas
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation 2Health News:Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation 3Health News:'That's My Hope' Audio Edition Released 2Health News:'That's My Hope' Audio Edition Released 3Health News:Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services 2Health News:Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services 3Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 2Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 3Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 4Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 5Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 6Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 7Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 8Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 9Health News:AND Calls on DoD to Open All Military Units to Women, Grant Parental Leave to Service Members 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 3
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2Fresh Blood Boosts Survival in Trauma Patients 58799 1Fresh Blood Boosts Survival in Trauma Patients 58799 2Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 1Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 2Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 3Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 4Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 5Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 1Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 2Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 3Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 4Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 5